• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • News
      All News Research Reports
    • Reports

    P
    Pharmaceuticals & Biotech.
    SECTOR | 12 Apr 2022

    PHARMA Q4FY22 PREVIEW: COST PRESSURE AND PRICING EROSION COMPRESS MARGINS

    buy
    Pharmaceuticals & Biotech.
    by Axis Direct
    Axis Direct
    OUR TOP POSITIVE PLAYS ARE: Cipla, Abbott India, KIMS, HCG
    Copy Link Share on Share on Share on Share on
    Alert  
    Axis Direct released a Sector Update report for Pharmaceuticals & Biotech. on 09 Jul, 2025.
    More from Pharmaceuticals & Biotech.
    Recommended
    Market closes lower, SBI plans a Rs 25,000 crore share sale via a QIP
    Trendlyne Marketwatch | 10 Jul 2025, 04:12PM
    Five winners from analysts: Stocks set to start FY26 with a bang | Screener: Stocks analysts are most …
    The Baseline | 10 Jul 2025, 12:14PM
    Volume-led growth, price stabilization and new US launches boost Indian pharma
    | 25 Mar 2024
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd